| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Okt―02 |
A-323 Investigating Shifts in Pathogen Prevalence Trends Pre- and Post-COVID-19 Pandemic in North Taiwan |
Li-An Wu |
| 2 |
[GO] |
2025―Okt―02 |
B-092 Humoral Immune Response after Prime and Boost Vaccination against SARS-CoV-2: a Follow-up Study among Healthcare Workers |
Hyun-Woo Choi, Chae-Hyeon Jeon, Seung-Ji Kang, Joo-Heon Park, Seung-Jung Kee |
| 3 |
[GO] |
2025―Okt―02 |
A-303 Fungal Prevalence and Epidemiology during and after the SARS-Cov-2 Pandemic: A Five-year Retrospective Study in Brazil (2020-2024) |
Jussimara Nurmberger, Fernanda Inoue, Samuel Gerson Vieira, Thais Turati, Ana Paula Lobo, Graziele Ferreira, Debora Ramadan, Sergio Tufik |
| 4 |
[GO] |
2025―Okt―02 |
B-119 Seroprevalence of SARS-CoV-2 IgG Spike and Nucleocapsid Antibodies in the Northeastern United States: 2023-2024 |
George Pratt, L V Rao |
| 5 |
[GO] |
2025―Okt―02 |
A-416 Clinical and Analytical Evaluation of the 15-minute, FDA-Cleared, CLIA-Waived, DASH® SARS-CoV-2 and Flu A/B Test Performed on the Point-of-Care DASH® Rapid PCR System |
Huiping Zhu, Mark Baumeister, Hannah Klug, Tina Arms, Skyler Cadenhead, Meredith Earp, Jeffrey Shelton, Michael Karberg, Sally McFall, James Hully |
| 6 |
[GO] |
2025―Okt―02 |
A-367 Rapid and Sensitive Real-time RT-PCR Point-of-Care System for Detection and Differentiation of Influenza A and B, RSV, and SARS-CoV-2 |
Rachel Behounek, Sohee Yun, Brigitte Beneteau, Willow Swinton, Nicola Carriglio, Elena Del Tordello, Sundaresh Brahmasandra, Giulia Minnucci, Janet Farhang |
| 7 |
[GO] |
2025―Okt―02 |
B-240 Respiratory Scout: fast and accurate home molecular testing for the detection and discrimination of influenza A/B, and SARS-CoV-2 |
Martin Kemper, Melissa Remmel, Rochelle Nguyen, Cameron Ball |
| 8 |
[GO] |
2025―Okt―02 |
A-304 Changes in the Antimicrobial Resistance Profile of the Staphylococcus aureus after the COVID-19 Pandemic |
Jussimara Nurmberger, Fernanda Inoue, Samuel Gerson Vieira, Talita Carniatto, Graziele Ferreira, Ana Paula Lobo, Debora Ramadan, Sergio Tufik |
| 9 |
[GO] |
2025―Okt―02 |
A-324 The Clinical Significance of Zinc to Copper Ratio in the Early Management of COVID-19 and its Association with Disease Severity and Mortality |
Amir Yarahmadi, Seyedeh Zahra Lotfi |
| 10 |
[GO] |
2025―Jan―21 |
How Can Digital PCR Support the Rapid Development of New Detection Tests in Future Pandemics? |
Helene Péré, David Veyer, Valerie Taly |
| 11 |
[GO] |
2025―Jan―03 |
SARS-CoV-2 Diversity and Transmission on a University Campus across Two Academic Years during the Pandemic |
Amanda M Casto, Miguel I Paredes, Julia C Bennett, Kyle G Luiten, Peter D Han, Luis S Gamboa, Evan McDermot, Geoffrey S Gottlieb, Zachary Acker, Natalie K Lo, Devon McDonald, Kathryn M McCaffrey, Marlin D Figgins, Christina M Lockwood, Jay Shendure, Timothy M Uyeki, Lea M Starita, Trevor Bedford, Helen Y Chu, Ana A Weil |
| 12 |
[GO] |
2024―Okt―02 |
B-152 Analysis of carbonyl compounds in exhaled breath for detection of COVID-19 |
X Fu, Z Xie, J D Morris, A D Alksas, A D El-Baz, J D Huang, M H Nantz |
| 13 |
[GO] |
2024―Okt―02 |
B-352 Effects of COVID-19 on Breast Cancer Positivity: A Retrospective and Predictive Study |
S S de Andrade, G Moreno Rodrigues de Souza, H Pagan Cilotti, D Ribeiro Ramadan-Boscolo, S Tufik |
| 14 |
[GO] |
2024―Okt―02 |
A-288 Active Surveillance Cultures: Frequency of Microorganisms and Phenotypic Resistance Profile From Brazilian Public Hospitals After COVID-19 Pandemic Peak |
S S de Andrade, J M Nurmberger, F M Inoue, A P Lobo, D R Ramadan-Boscolo, S Tufik |
| 15 |
[GO] |
2024―Okt―02 |
B-136 From Result to Response: The Development of Laboratory-Based Scoring Models to Predict COVID-19 Patient Outcomes |
M S Scott, O Vishnyakova, L Elliot, G Morgan, S Casalino, E Frangione, E Lapadula, S Haller, S Thakur, Z Khan, I Wong, R Nomigolzar, G MacDonald, S Arnoldo, E Bearss, A Binnie, B Borgundvaag, L Devine, D Richardson, S Stern, A Taher, J Lerner-Ellis, J Taher |
| 16 |
[GO] |
2024―Okt―02 |
A-240 Validation of the OSOM Flu SARS-CoV-2 Combo Home Test |
S Yaji, K Shimizu, D Fong, E Gonzalez, T Aihara, N Delgado Flores, K Dennis, T Nguyen-Brown, K Cox, A Baytan, J Schenken, M Morita, A Chun, D Nair-Schaef |
| 17 |
[GO] |
2024―Okt―02 |
B-050 A comparison of two semi-quantitative tests, Abbott’s Advise DX SARS-CoV-2 IgG II and Beckman Coulter’s Access SARS-COV-2 IgG II, for measuring IgG antibody levels after Sars-CoV-2 Pfizer-BioNTech vaccination |
W Niklinski, E Niklinska, S Siddiqui, D Ferrer Peace |
| 18 |
[GO] |
2024―Okt―02 |
A-019 Unexpectedly High Cardiac Troponin Values in Healthy Athletes after SARS-CoV-2 Infection |
A Hammerer-Lercher, C Kissel, S Wittfooth, G Huré, A Sanzone, P Neyer, L Bernasconi, R Manka, P Noack, D Hof, O Hammarsten, C Mueller |
| 19 |
[GO] |
2024―Okt―02 |
A-235 Systemic Inflammation is associated with worse outcomes from SARS-CoV-2 infection but not neutralizing antibody |
C Farnsworth, L Jackson, B Roemmich, D Daghfal, G Murtagh, E Frias, T Griffiths, G Davis, C Jacobson, N Jeanblanc |
| 20 |
[GO] |
2024―Okt―02 |
B-087 Sars-cov-2 Nt Chip test performance: a novel microarray-based enzymatic immunoassay for in vitro identification of neutralizing antibodies against emerging variants |
J Levi, J F de Souza, V Vidotto Frade, A F Justino Feo, G Laginestra Francisco, D Rodrigues de Sousa, A Correa Wengerkievicz Lopes, F Moruzzi, G Justamante Händel Schmitz, M Kintrup |
| 21 |
[GO] |
2024―Okt―02 |
A-233 Wastewater-based surveillance for SARS-CoV-2 Subvariants using the Nanopore Sequencing in South Korea |
Y Kim, T Noh, S Lee, Y Kim, K Lee |
| 22 |
[GO] |
2024―Okt―02 |
B-086 Evaluation of Long-Term Adaptive Immune Responses Specific to SARS-CoV-2: Effect of Various Vaccination and Omicron Exposure |
E Oh, H Kang, J Jung, J Lee, G Ko, H Park, A Choi |
| 23 |
[GO] |
2024―Okt―02 |
B-026 Transforming PCR protocols in pandemic response with automated non-contact liquid dispensing |
L Henry, F Pitt, S Mulla, T Redgwell, D Grovewood, R Buckley-Taylor, S Lee, G Fedele, G Hill, P Harper, D Fraser |
| 24 |
[GO] |
2024―Okt―02 |
A-287 Mycoplasma pneumoniae outbreak in 2023: Post pandemic resurgence of an atypical bacterial pathogen |
V Singh, P Upadhyay |
| 25 |
[GO] |
2024―Jul―16 |
Is Long COVID a Complement Dysregulation Disease? |
Wioleta M Zelek |
| 26 |
[GO] |
2023―Dez―01 |
Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination |
Christopher D Heaney, Heidi Hempel, Kate L DeRosa, Ligia A Pinto, Nicholas J Mantis |
| 27 |
[GO] |
2023―Sep―27 |
A-294 Duplicate Testing of Samples Suspected of SARS-CoV-2 Infection Could Prevent Misdiagnosis of Covid-19 |
J Sánchez-Sánchez, G Thapa, A Mylona, R Vuono |
| 28 |
[GO] |
2023―Sep―27 |
A-249 Theranostic Algorithm: sensitivity and Specificity of a Composite Index Test for Guiding Treatment in Severe COVID-19 |
N V De Vos, M Bruyneel, C Duterme, A Roman, H Dahma, S Alard, S Andre, D Barglazan, A Chirumberro, F Cotton |
| 29 |
[GO] |
2023―Sep―27 |
A-372 Increased Sensitivity in Detection of SARS-CoV-2 Antigen Using RADI COVID-19 Ag Rapid Test |
S Kee, J Choi, J Jeon, M Heo, J Park, H Choi |
| 30 |
[GO] |
2023―Sep―27 |
B-147 Evaluation of Laboratory Database: Is there a Causal Relationship between COVID-19 and Type 1 Diabetes |
M C Castelo, M Cruz, S P Bandeira, A C Lopes, L L Cavalcante |
| 31 |
[GO] |
2023―Sep―27 |
A-378 Clinical Evaluation and Implementation of Rapid COVID-19 Antigen Test in Qatar |
J S Said, F Afreen, D Al-Wali, E A Al Kuwari, Z M Kabir, A M Salem |
| 32 |
[GO] |
2023―Sep―27 |
A-231 Prediction of Severe COVID-19 Based on Routine Biomarker Assessment |
H Kapoor, C Bi, A E Salm, J Szymanski, Y D Goldstein, L R Wolgast, G Rosenblatt, A S Fox, M H Kroll |
| 33 |
[GO] |
2023―Sep―27 |
A-336 Comparison Between the Immune Profile of Pregnant and Postpartum Women with and without COVID-19 by Flow Cytometry |
M L Machado, A T de Souza, S E Silva, A L Fonseca, J D Camargo, A J Vale, E P Azevedo, G H Oliveira, A D Luchessi, G B Junior, V N Silbiger, R N Cobucci |
| 34 |
[GO] |
2023―Sep―27 |
A-229 Immune Biomarkers Associated with COVID-19 Disease Severity in an Urban, Hospitalized Population |
A B Chambliss, M Aljehani, B Tran, X Chen, E Elton, C Garri, N Ung, N Matasci, M E Gross |
| 35 |
[GO] |
2023―Sep―27 |
A-123 Increased Rate of Recurrent Hemolysis Is Associated With COVID-19 Infection and Propofol Administration in the Intensive Care Unit (ICU) |
R Fyffe-Freil, A A Wockenfus, E A Hain, M A Nicklas, N A Baumann, B M Katzman |
| 36 |
[GO] |
2023―Sep―27 |
A-087 Relationship among Different Inflammatory Markers in Patients with COVID-19 Infections |
R Yadav, P Chopra, T Sehgal, S K Datta, A Ningombam, A Ahirwar |
| 37 |
[GO] |
2023―Sep―27 |
A-136 Usefulness of Presepsin and Thrombomodulin Measurements for Predicting COVID-19 Mortality |
A Yamazaki, Y Nukui, T Kameda, R Saito, Y Koda, N Ichimura, S Tohda, R Ohkawa |
| 38 |
[GO] |
2023―Sep―27 |
A-175 Objective Indexes for Comparing Platelet Usage Among Peer Hospitals During the COVID-19 Pandemic |
Y Tu, Y Hsueh, Y Cheng, T Lin, T Chiueh |
| 39 |
[GO] |
2023―Sep―27 |
A-292 The Use of Third-Party Controls During Covid-19 Pandemic: An Alternative to the Lack of Other Respiratory Infections |
J Sánchez-Sánchez |
| 40 |
[GO] |
2023―Sep―27 |
B-046 Curious Thing, an Artificial Intelligence (AI) Based Conversational Agents in COVID-19 Patient Management |
J S Chow |
| 41 |
[GO] |
2023―Sep―27 |
A-289 Emergence of Unusual Non-Fermentative Gram-Negative Bacilli Associated to COVID-19 Period at Brazilian Hospitals |
J M Nurmberger, F M Inoue, A T Lobo, D R Ramadan, S Tufik |
| 42 |
[GO] |
2023―Sep―27 |
B-045 A Descriptive Study of the Clinical Impacts on COVID-19 Survivors Using Telemonitoring (The TeleCOVID Study) |
J S Chow |
| 43 |
[GO] |
2023―Sep―27 |
A-275 Clinical Evaluation of SMARTCHEK® SARS-CoV-2 Detection Kit and SMARTCHEK® SARS-CoV-2 Fast Detection Kit for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nasopharyngeal Swabs |
J Ahn, W Lee, S Yoon, S Cho |
| 44 |
[GO] |
2023―Sep―27 |
A-276 Clinical Performance Evaluation of SMARTCHEK® SARS-CoV-2 Detection Kit and SMARTCHEK® SARS-CoV-2 Fast Detection Kit for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Saliva |
S Park, J Yoo, S Cho |
| 45 |
[GO] |
2023―Sep―27 |
B-013 Association Between Laboratory Parameters Analysis and Clinical Severity in Patients With Coronavirus Disease (Covid 19) at Hospital Universitario Fundación Santa Fe |
O Martinez Nieto, H A Gonzalez, C E Saavedra Andrade, D M Bertel Rodriguez, P A Rodriguez Urrego, J P Vargas Gallo |
| 46 |
[GO] |
2023―Sep―27 |
A-259 Detecting Human RNase P Gene Prevents False-Negative of SARS-CoV-2 |
F Chuang |
| 47 |
[GO] |
2023―Sep―27 |
B-085 Sars-cov-2 nt-chip: A Multiplex eia Platform for Detect Humoral Response and Neutralizing Antibodies Against Sars-cov-2 |
J R Siqueira, M L Moreira, E M Carvalho, F Moruzzi, D D Luche, M Kintrup |
| 48 |
[GO] |
2023―Sep―27 |
A-347 Performance Evaluation of Standard Q COVID/FLU Ag Combo for Detection of SARS-CoV-2 and Influenza A and B Antigens from the Patients with Suspected Respiratory Infections |
S Kim, W Choi |
| 49 |
[GO] |
2023―Sep―27 |
B-158 Application of Statistical Analysis as a Tool to Monitor the Variation of SARS-CoV-2 and Other Respiratory Viruses |
G C Carvalho, J M Nurmberger, B B Perez, D R Ramadan, S Tufik |
| 50 |
[GO] |
2023―Sep―27 |
A-265 Disparities Among SARS-CoV-2 Antibody Positivity in Healthcare Workers |
K E Mullins, R Christenson |
| 51 |
[GO] |
2023―Sep―27 |
B-077 Comparison of SARS-CoV-2 Antibody Profile and Omicron-Specific Neutralizing Activity Before and After mRNA Booster Vaccines: Bivalent vs. Original Formulation |
A Windau, J Meyers, X Yang, R Pontoni, C Schmotzer, J Noguez, F Dong, X S Zhang |
| 52 |
[GO] |
2023―Sep―27 |
A-235 Results and Interpretation: Serology Testing Platforms and Assays Compatibility Assessment for MASTM SARS-CoV-2 IgG Quality Controls |
H Wang, N Krishnaswami, D Crandall, R Hu |
| 53 |
[GO] |
2023―Sep―27 |
B-108 T-cell-mediated Immunity against SARS-CoV-2 in Health Care Workers: Head-to-head Comparison of Two Interferon-Gamma Release Assays and Associations between Cellular and Humoral Immunity |
M Sabalza, J Martinek, H Tomášková, A Lochmanová, H Zelená, J Motlochová, K Dieckmann, E Grage-Griebenow, S Saschenbrecker, D Zapf, V Herbst, E Ježo, J Janošek |
| 54 |
[GO] |
2023―Sep―27 |
B-251 Nmr Lipoproteins Help to Reveal Subphenotypes of Phenoreversion from sars-cov-2 Infection |
J Wist, S Lodge, R Masuda, P Nitschke, C Cannet, H Schaefer, H Ruffieux, G Bantug, C Hess, E Holmes, J K Nicholson |
| 55 |
[GO] |
2023―Sep―27 |
A-022 Muscle and Cardiac Marker Levels Impact for SARS-CoV-2 Infection |
G C Carvalho, R P Carvalho, D R Ramadan, S Tufik |
| 56 |
[GO] |
2023―Sep―27 |
A-252 Differentiation of SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus Using a Single Swab: A Clinical Performance Evaluation of the BD MAX System Multiplex PCR Assay |
M Faron, N Ledeboer, B Van Der Pol, T Davis, E Lockamy, S Paradis, J Andrews |
| 57 |
[GO] |
2023―Sep―27 |
A-282 Coinfection Rates of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus |
G W Pratt, M Platt, C Wong, L V Rao |
| 58 |
[GO] |
2023―Sep―27 |
B-091 Assessing Postvaccination SARS-CoV-2 Neutralizing Antibodies at Different Timepoints: a Laboratory-Based Study |
G M Souza, G C Carvalho, R A Nunes, F M Cristaldi, D R Ramadan, S Tufik |
| 59 |
[GO] |
2023―Sep―27 |
B-089 Development of a Secondary Standard for Quantitation of IgG Antibodies to SARS-CoV-2 Proteins in a Multiplex Assay |
N Venkateswaran, J Sarwar, W M Nelson, K S Venkateswaran |
| 60 |
[GO] |
2023―Sep―27 |
B-230 Monitoring SARS-CoV-2 Subvariants for Evaluation of the Diagnostic Kit’s Annealing Site Using Nanopore Sequencing |
Y Kim, T Noh, S Lee, Y Kim, D Prakash, K Lee |
| 61 |
[GO] |
2023―Sep―27 |
A-278 Development and Validation of Platform Independent, Turbidimetric Sars-CoV-2 Total Antibody Assay |
M Jaquemar, T Nilsen, A Safdari, A Haukebø, E Trosten, A Havelka, Ø Olsvik |
| 62 |
[GO] |
2023―Sep―27 |
A-307 Spread Dynamic of SARS-CoV-2 Variants and Related Alterations in Transmission Rates: A National Scale Study |
J D Silva, A B de Lima, L B Alvim, F S Malta, C P Mendonça, P L Fonseca, R P de Souza, R S de Aguiar, D A Zauli |
| 63 |
[GO] |
2023―Sep―27 |
A-086 Vitamin D and its Variation in a Pandemic Context: Pre-pandemic-Intra-pandemic-Post-pandemic Analysis in the Province of Buenos Aires - Argentina |
P N Canala, M D Canala, M Spiccia, G Ghioni |
| 64 |
[GO] |
2023―Mai―10 |
Correction to: Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection |
|
| 65 |
[GO] |
2022―Jul―27 |
Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection |
Anda Bularga, Ellen Oskoui, Takeshi Fujisawa, Sara Jenks, Rachel Sutherland, Fred S Apple, Ola Hammarsten, Nicholas L Mills |
| 66 |
[GO] |
2022―Jul―27 |
Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection |
Peter A Kavsak |
| 67 |
[GO] |
2022―Jul―27 |
Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection |
Bernard Croal |
| 68 |
[GO] |
2022―Jun―07 |
PCR-Based Screening Tests for SARS-CoV-2 Mutations: What Is the Best Way to Identify Variants? |
Akira Aoki, Yoko Mori, Yoshinori Okamoto, Hideto Jinno |
| 69 |
[GO] |
2021―Dez―05 |
Subclinical myocardial injury and risk of COVID-19 in the general population: The Trøndelag Health Study |
Magnus Nakrem Lyngbakken, Kristian Hveem, Helge Røsjø, Torbjørn Omland |
| 70 |
[GO] |
2021―Okt―19 |
Save the COVID-19 point of care nucleic acid test swab after testing to identify variants of concern |
Byron M Berenger, William Stokes, Leeann Turnbull, Kanti Pabbaraju, Nathan Zelyas, Allison A Venner, Graham A Tipples |
| 71 |
[GO] |
2021―Okt―05 |
COVID-19 Testing and a Path out of the Pandemic |
Gigi Gronvall |
| 72 |
[GO] |
2021―Aug―10 |
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking |
Hui Chen, Zhao Li, Sheng Feng, Melissa Richard-Greenblatt, Emily Hutson, Stefen Andrianus, Laurel J Glaser, Kyle G Rodino, Jianing Qian, Dinesh Jayaraman, Ronald G Collman, Abigail Glascock, Frederic D Bushman, Jae Seung Lee, Sara Cherry, Alejandra Fausto, Susan R Weiss, Hyun Koo, Patricia M Corby, Alfonso Oceguera, Una O’Doherty, Alfred L Garfall, Dan T Vogl, Edward A Stadtmauer, Ping Wang |
| 73 |
[GO] |
2021―Aug―05 |
Poor Humoral Response in Solid Organ Transplant Recipients following Complete mRNA SARS-CoV-2 Vaccination |
Jing Cao, Xiaohui Liu, Alagarraju Muthukumar, Jeffrey Gagan, Patricia Jones, Youli Zu |
| 74 |
[GO] |
2021―Aug―04 |
Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection |
Yu Zhang, Chui Mei Ong, Cassandra Yun, Weike Mo, Jeffery D Whitman, Kara L Lynch, Alan H B Wu |
| 75 |
[GO] |
2021―Jul―28 |
Wide Variation in Cycle Threshold Values Cloud the Interpretation of COVID-19 Infectiousness |
William Stokes, Jamil Kanji, Jia Hu, Nathan Zelyas, Byron M Berenger |
| 76 |
[GO] |
2021―Jun―09 |
Mechanisms of myocardial injury in COVID-19 |
Anda Bularga, Andrew R Chapman, Nicholas L Mills |
| 77 |
[GO] |
2021―Apr―28 |
TOP-Plus is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability |
Sabrina E Racine-Brzostek, Mohsen Karbaschi, Christian Gaebler, P J Klasse, Jim Yee, Marina Caskey, He S Yang, Ying Hao, Ashley Sukhu, Sophie Rand, Amy Chadburn, Yuanyuan Shi, Robert Zuk, Michel C Nussenzweig, Melissa M Cushing, Zhen Zhao |
| 78 |
[GO] |
2021―Jan―04 |
Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of patients with mild COVID-19: clinical sensitivity, specificity and association with virus neutralization test |
Antonin Bal, Bruno Pozzetto, Mary-Anne Trabaud, Vanessa Escuret, Muriel Rabilloud, Carole Langlois-Jacques, Adèle Paul, Nicolas Guibert, Constance D’Aubarede-Frieh, Amélie Massardier-Pilonchery, Nicole Fabien, David Goncalves, André Boibieux, Florence Morfin-Sherpa, Virginie Pitiot, François Gueyffier, Bruno Lina, Jean-Baptiste Fassier, Sophie Trouillet-Assant |
| 79 |
[GO] |
2020―Dez―16 |
Assessment of multiplex digital droplet RT-PCR as a diagnostic tool for SARS-CoV-2 detection in nasopharyngeal swabs and saliva samples |
Kévin Cassinari, Elodie Alessandri-Gradt, Pascal Chambon, Françoise Charbonnier, Ségolène Gracias, Ludivine Beaussire, Kevin Alexandre, Nasrin Sarafan-Vasseur, Claude Houdayer, Manuel Etienne, François Caron, Jean Christophe Plantier, Thierry Frebourg |
| 80 |
[GO] |
2020―Dez―12 |
Implementation of Reverse Transcriptase Polymerase Chain Reaction Testing for Severe Acute Respiratory Syndrome Coronavirus-2 Under the U.S. Food and Drug Administration Emergency Use Authorization |
Joel A Lefferts, Samantha F Allen, Heather B Steinmetz, Gregory J Tsongalis |
| 81 |
[GO] |
2020―Dez―01 |
Corrigendum to SARS-CoV-2 Serology: Much Hype, Little Data |
|
| 82 |
[GO] |
2020―Nov―04 |
DNA cross-reactivity of the CDC-specified SARS-COV-2 specimen control leads to potential for false negatives and underreporting of viral infection |
Adam P Rosebrock |
| 83 |
[GO] |
2020―Okt―10 |
Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results |
Peter A Kavsak, Ola Hammarsten, Andrew Worster, Stephen W Smith, Fred S Apple |
| 84 |
[GO] |
2020―Okt―10 |
Deus ex machina? Predicting SARS-CoV-2 Infection from Lab Tests Using Machine Learning |
Christopher R McCudden |
| 85 |
[GO] |
2020―Sep―18 |
Mass Spectrometry for COVID-19 |
Jeffrey A SoRelle, Khushbu Patel, Laura Filkins, Jason Y Park |
| 86 |
[GO] |
2020―Sep―04 |
Cautionary note on contamination of reagents used for molecular detection of SARS-CoV-2 |
Jim F Huggett, Vladimir Benes, Stephen A Bustin, Jeremy A Garson, Karthyn Harris, Martin Kammel, Mikael Kubista, Timothy D McHugh, Jacob Moran-Gilad, Tania Nolan, Michael W Pfaffl, Marc Salit, Greg Shipley, Peter M Vallone, Jo Vandesompele, Carl Wittwer, Heinz Zeichhardt |
| 87 |
[GO] |
2020―Sep―04 |
Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies |
Gang Xu, Anthony J Emanuel, Satish Nadig, Shikhar Mehrotra, Brittany A Caddell, Scott R Curry, Frederick S Nolte, Nikolina Babic |
| 88 |
[GO] |
2020―Aug―19 |
Routine laboratory blood tests predict SARS-CoV-2 infection using machine learning |
He S Yang, Yu Hou, Ljiljana V Vasovic, Peter Steel, Amy Chadburn, Sabrina E Racine-Brzostek, Priya Velu, Melissa M Cushing, Massimo Loda, Rainu Kaushal, Zhen Zhao, Fei Wang |
| 89 |
[GO] |
2020―Aug―07 |
Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity |
Thomas Perkmann, Nicole Perkmann-Nagele, Marie-Kathrin Breyer, Robab Breyer-Kohansal, Otto C Burghuber, Sylvia Hartl, Daniel Aletaha, Daniela Sieghart, Peter Quehenberger, Rodrig Marculescu, Patrick Mucher, Robert Strassl, Oswald F Wagner, Christoph J Binder, Helmuth Haslacher |
| 90 |
[GO] |
2020―Jul―24 |
SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission |
Divinlal Harilal, Sathishkumar Ramaswamy, Tom Loney, Hanan Al Suwaidi, Hamda Khansaheb, Abdulmajeed Alkhaja, Rupa Varghese, Zulfa Deesi, Norbert Nowotny, Alawi Alsheikh-Ali, Ahmad Abou Tayoun |
| 91 |
[GO] |
2020―Jul―20 |
The cause of Severe Acute Respiratory Syndrome: What did we learn from it? |
Malik Peiris, Leo L M Poon |
| 92 |
[GO] |
2020―Mai―30 |
Clinical Performance of the Roche SARS-CoV-2 Serologic Assay |
Mei San Tang, Karl G Hock, Nicole M Logsdon, Jennifer E Hayes, Ann M Gronowski, Neil W Anderson, Christopher W Farnsworth |
| 93 |
[GO] |
2020―Mai―30 |
Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies |
Julien Favresse, Christine Eucher, Marc Elsen, Tré-Hardy Marie, Jean-Michel Dogné, Jonathan Douxfils |
| 94 |
[GO] |
2020―Mai―20 |
Molecular and serological assays for SARS-CoV-2: insights from genome and clinical characteristics |
Jiping Shi, Dongsheng Han, Runling Zhang, Jinming Li, Rui Zhang |
| 95 |
[GO] |
2020―Mai―12 |
Clinical Performance of Two SARS-CoV-2 Serologic Assays |
Mei San Tang, Karl G Hock, Nicole M Logsdon, Jennifer E Hayes, Ann M Gronowski, Neil W Anderson, Christopher W Farnsworth |
| 96 |
[GO] |
2020―Mai―06 |
Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher (exo-IQ) |
Ole Behrmann, Iris Bachmann, Martin Spiegel, Marina Schramm, Ahmed Abd El Wahed, Gerhard Dobler, Gregory Dame, Frank T Hufert |
| 97 |
[GO] |
2020―Mai―04 |
Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization |
Vikas Peddu, Ryan C Shean, Hong Xie, Lasata Shrestha, Garrett A Perchetti, Samuel S Minot, Pavitra Roychoudhury, Meei-Li Huang, Arun Nalla, Shriya B Reddy, Quynh Phung, Adam Reinhardt, Keith R Jerome, Alexander L Greninger |
| 98 |
[GO] |
2020―Apr―29 |
Modeling SARS-CoV-2 positivity using laboratory data: timing is everything |
Thor Larson, Karissa Culbreath, Dennis Chavez, Richard Larson, Michael Crossey, David G Grenache |
| 99 |
[GO] |
2020―Apr―28 |
SARS-CoV-2 Serology: Much Hype, Little Data |
Christopher W Farnsworth, Neil W Anderson |
| 100 |
[GO] |
2020―Apr―17 |
Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform |
Lin Yu, Shanshan Wu, Xiaowen Hao, Xue Dong, Lingling Mao, Vicent Pelechano, Wei-Hua Chen, Xiushan Yin |
| 101 |
[GO] |
2020―Apr―11 |
Limits of Detection of Six Approved RT-PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2) |
Xueliang Wang, Hangping Yao, Xing Xu, Pengyin Zhang, Minmin Zhang, Junbin Shao, Yanqun Xiao, Hualiang Wang |
| 102 |
[GO] |
2020―Apr―02 |
Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads |
Yang Pan, Luyao Long, Daitao Zhang, Tingting Yan, Shujuan Cui, Peng Yang, Quanyi Wang, Simei Ren |
| 103 |
[GO] |
2020―Mrz―09 |
The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception |
Ping Wang, Neil Anderson, Yang Pan, Leo Poon, Carmen Charlton, Nathan Zelyas, David Persing, Daniel Rhoads, Hilary Babcock |
| 104 |
[GO] |
2020―Feb―19 |
Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak |
Matthew J Binnicker |
| 105 |
[GO] |
2020―Feb―06 |
Racing towards the development of diagnostics for a novel coronavirus (2019-nCoV) |
Y M Dennis Lo, Rossa W K Chiu |
| 106 |
[GO] |
2020―Jan―28 |
Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia |
Daniel K W Chu, Yang Pan, Samuel M S Cheng, Kenrie P Y Hui, Pavithra Krishnan, Yingzhi Liu, Daisy Y M Ng, Carrie K C Wan, Peng Yang, Quanyi Wang, Malik Peiris, Leo L M Poon |
|
